Temporal regulation of gene expression through integration of p53 dynamics and modifications.


Journal

Science advances
ISSN: 2375-2548
Titre abrégé: Sci Adv
Pays: United States
ID NLM: 101653440

Informations de publication

Date de publication:
25 Oct 2024
Historique:
medline: 25 10 2024
pubmed: 25 10 2024
entrez: 25 10 2024
Statut: ppublish

Résumé

The master regulator of the DNA damage response, the transcription factor p53, orchestrates multiple downstream responses and coordinates repair processes. In response to double-strand DNA breaks, p53 exhibits pulses of expression, but how it achieves temporal coordination of downstream responses remains unclear. Here, we show that p53's posttranslational modification state is altered between its first and second pulses of expression. We show that acetylations at two sites, K373 and K382, were reduced in the second pulse, and these acetylations differentially affected p53 target genes, resulting in changes in gene expression programs over time. This interplay between dynamics and modification may offer a strategy for cellular hubs like p53 to temporally organize multiple processes in individual cells.

Identifiants

pubmed: 39454005
doi: 10.1126/sciadv.adp2229
doi:

Substances chimiques

Tumor Suppressor Protein p53 0
TP53 protein, human 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

eadp2229

Auteurs

Dan Lu (D)

Department of Systems Biology, Blavatnik Institute at Harvard Medical School, Boston, MA 02115, USA.

Marjan Faizi (M)

Department of Systems Biology, Blavatnik Institute at Harvard Medical School, Boston, MA 02115, USA.

Bryon Drown (B)

Department of Chemistry, Northwestern University, Evanston, IL 60208, USA.

Alina Simerzin (A)

Department of Systems Biology, Blavatnik Institute at Harvard Medical School, Boston, MA 02115, USA.

Joshua François (J)

Department of Systems Biology, Blavatnik Institute at Harvard Medical School, Boston, MA 02115, USA.

Gary Bradshaw (G)

Laboratory of Systems Pharmacology, Blavatnik Institute at Harvard Medical School, Boston, MA 02115, USA.

Neil Kelleher (N)

Department of Chemistry, Northwestern University, Evanston, IL 60208, USA.

Ashwini Jambhekar (A)

Department of Systems Biology, Blavatnik Institute at Harvard Medical School, Boston, MA 02115, USA.
Ludwig Center at Harvard Medical School, Boston, MA 02115, USA.

Jeremy Gunawardena (J)

Department of Systems Biology, Blavatnik Institute at Harvard Medical School, Boston, MA 02115, USA.

Galit Lahav (G)

Department of Systems Biology, Blavatnik Institute at Harvard Medical School, Boston, MA 02115, USA.
Ludwig Center at Harvard Medical School, Boston, MA 02115, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH